Clinical trial
Safety and Efficacy Evaluation of iAPA-DC/CTL Combined Gemcitabine Therapy on Advanced Pancreatic Cancer
NCT02529579 is registered in ClinicalTrials.gov with Changhai Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy Evaluation of iAPA-DC/CTL Combined Gemcitabine Therapy on Advanced Pancreatic Cancer
- Lead sponsor
- Changhai Hospital
- Phase
- Phase 1/2
- Overall status
- Unknown status
- Start date
- June 30, 2015
- Completion date
- December 31, 2019
- Enrollment
- 187 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.